Natural Alternatives Common Stock Net 2012-2025 | NAII

Natural Alternatives common stock net from 2012 to 2025. Common stock net can be defined as the value of common equity ownership.

Natural Alternatives Common Stock Net 2012-2025 | NAII

Natural Alternatives common stock net from 2012 to 2025. Common stock net can be defined as the value of common equity ownership.
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$75.3B
Zoetis (ZTS)$68.1B
Takeda Pharmaceutical (TAK)$46.9B
Daiichi Sankyo, - (DSNKY)$43.1B
BeOne Medicines - (ONC)$29.6B
Sandoz Group AG (SDZNY)$25B
Summit Therapeutics (SMMT)$18.1B
Merck (MKKGY)$16.5B
Shionogi (SGIOY)$14.2B
United Therapeutics (UTHR)$13.2B
Neurocrine Biosciences (NBIX)$13B
Orion OYJ (ORINY)$11B
IPSEN (IPSEY)$10.2B
Stevanato Group S.p.A (STVN)$7.8B
Corcept Therapeutics (CORT)$7.6B
Madrigal Pharmaceuticals (MDGL)$6.9B
Grifols, S.A (GRFS)$6.7B
Ionis Pharmaceuticals (IONS)$6.7B
Hikma Pharmaceuticals Plc (HKMPF)$6.2B
Ono Pharmaceutical (OPHLF)$5.3B
Soleno Therapeutics (SLNO)$4.2B
Hypermarcas (HYPMY)$3.2B
Crinetics Pharmaceuticals (CRNX)$3B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.6B
NewAmsterdam Pharma (NAMS)$2.4B
Centessa Pharmaceuticals (CNTA)$2B
BioCryst Pharmaceuticals (BCRX)$1.8B
Ocular Therapeutix (OCUL)$1.8B
ARS Pharmaceuticals (SPRY)$1.7B